Patient satisfaction and quality of vision following implantation of latest technology based Intraocular Lens implantation after cataract surgery in both eyes
- Conditions
- Health Condition 1: H251- Age-related nuclear cataract
- Registration Number
- CTRI/2020/08/027105
- Lead Sponsor
- Dr Sri Ganesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
A patient with cataract for which phacoemulsification or femtolaser assisted cataract surgery with
posterior chamber IOL implantation
· Male or female in good general health, 40-80 years of age at the time of the pre-operative
examination
· A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL
implantation
· A patient with preoperative corneal astigmatism less than 1D and stable corneal conditions within
the last 12 months
· A patient with clear ocular media other than cataract in each eye
· A patient with normal OCT of the macula in each eye
A patient with a known pathology that may affect visual acuity (as determined by the Investigator);
particularly retinal changes that affect vision (macular degeneration, cystoid macular edema,
proliferative diabetic retinopathy, etc.) in either eye
A patient with amblyopia or strabismus
A patient with capsule or zonular abnormalities that may affect postoperative centration or tilt of the
lens (e.g. pseudoexfoliation syndrome) in either eye
A patient has a history of significant ocular trauma or prior ocular surgery in either eye
A patient with cornea guttata, corneal scarring, keratoplasty, irregular astigmatism (e.g.
Keratoconus)
A patient that may or is expected to undergo surgical intervention and/or ocular laser treatment prior
to or during the study period in either eye
Need for a dioptre out of the range of +16.0D to +26.0D
A patient with any uncontrolled systemic disease. A potential patient in whom therapy for a systemic
disease is not yet stabilized will not be considered for entry into the study
A patient currently participating or has participated within 30 days prior to the start of this study in a
drug or other investigational research study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method